SKC&C's Watson-based AI 'Aibril' become a doctor's medical adviser

SKC&C held AI'Aibril' Healthcare Seminar with doctors at SK U-tower SKC&C Park Jung-ho CEO invited medical doctors of large-scale domestic hospital to discuss AI'AIbril' healthcare seminar on Nov. 4 at the SK U-tower in Bundang, Seongnam city . The seminar was organized to explore ways to create an eco-friendly environment in the domestic artificial intelligence healthcare industry, which grows with domestic hospitals, by opening'the path of innovation of advisory service treating a disease using Abril'. The seminar will include major Korean hospitals such as Seoul National University Hospital, Korea University Medical Center, Seoul Asan Medical Center and Seoul Samsung Hospital, as well as partners in the SKC& C Lee Ki-yeol executive director of digital / financial division of SK C&C. and IBM Watson Todd Kalyniuk include about 30 doctors and medical information staff attended. In the greetings, executive director Lee received a great response from attendees by introducing the "Aibril" advisory service for various diseases to be introduced. Attendees at the hospital said that Aibril can analyze hundreds of millions of pages of medical information, including medical papers, hundreds of medical journals and textbooks, poured tens of thousands of each year by disease When a doctor asks his questions, "Aibril" responded well to the doctor's understanding of the intent of the question and to communicate in real-time with the doctor in a conversational way. In fact, IBM Watson Todd Kalyniuk, a global healthcare partner, introduced the cancer treatment advisory solution'Watson for Oncology' to understand the complex questions presented in natural language and suggest evidence-based answers do search for 15 million pages of vast amounts of medical information and offer 2-3 treatment options in a matter of seconds.